home

welcome to EBF

Welcome to the website of the European Bioanalysis Forum (EBF) 

June: Brussels 2012

November: Barcelona 2011

EBF 3rd Focus Meeting "Hatching" on Emerging Technologies Approaching the Regulated Bioanalysis Laboratory. Slide decks of the of the oral presentations of the 2011 Open Symposium "Less is More" have been made available at the conference site


EBF members (Hagenthal meeting May 2009)

EBF is an organisation comprised of bioanalytical scientists working within the pharmaceutical industry R&D. The scope of EBF is on bioanalysis of small and large molecules with 'bioanalysis' being defined as:

  • quantification of drug and metabolites in body fluids and tissues
  • quantification of PD and safety biomarkers amenable to conventional bioanalytical techniques
  • bioanalytical characterization of NBEs

We discuss on regulatory issues and aspects (new guidelines, interpretation of existing guidelines) and present our joint opinion towards regulatory bodies and our peers. Further, we share common practices - outside the IP area - on procedures, science, LIMS, validation, quality (GLP), etc and we discuss new developments in industry.


Disclaimer
The views expressed on this website are those of the European Bioanalysis Forum and do not necessarily reflect the representative company's position on the subject.